A comparison of HIV infection to other viral diseases in which protective immunity is achieved, reveals that the most glaring defect in HIV-1 infection is the lack of virus-specific CD4 helper cell function. Dr. Walker's laboratory recently identified vigorous HIV-specific CD4 proliferative responses in a subset of long-term non-progressors (LTNP) with extremely low viral loads, providing conclusive evidence that such responses can be elicited by HIV. The investigators hypothesize that CD4 helper cell function is lost in HIV infected persons due to activation and depletion of these cells during the period of peak viremia which accompanies primary infection. Furthermore, they hypothesize that potent antiviral therapy may be able to restore these responses, and the persistence of these cells is a key factor in the maintenance of both the asymptomatic state as well as B cell responses to viral proteins. An additional hypothesis states that dendritic cells are a key factor in leading to selective death of CD4 helper T-cells. To address this latter hypothesis, the P.I. will draw upon the considerable complementary expertise of Dr. Ralph Steinman in the area of dendritic cells and Dr. John Moore in the area of humoral immunity. The collective goal of the IRPG is to learn to generate better resistance to HIV-1. The investigators specifically propose to a) determine the proliferative response to HIV-1 p24 and gp160 in LTNP with low and high viral loads, rapid progressors, and recent seroconvertors; b) determine whether combination antiretroviral therapy administered at the time of seroconversion or during chronic infection can restore HIV-1 specific proliferative responses; c) define helper cell responses in terms of cytokine production and target epitopes, using dendritic cell clusters presenting HIV-1 and CD4 T cells as a source for cloning HIV-specific CD4 cell lines; d) define the role of APC in maintenance of HIV-specific helper cell function; and e) determine whether presentation of infectious virions via dendritic cells leads to selective death of T helper cells.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI040873-01A1
Application #
2432819
Study Section
Special Emphasis Panel (ZRG5-AAR (01))
Project Start
1997-09-30
Project End
2001-08-31
Budget Start
1997-09-30
Budget End
1998-08-31
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02199
Lentz, Margaret R; Kim, Woong-Ki; Kim, Hyun et al. (2011) Alterations in brain metabolism during the first year of HIV infection. J Neurovirol 17:220-9
Rosenberg, Eric S; Graham, Barney S; Chan, Ellen S et al. (2010) Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection. PLoS One 5:e10555
Lentz, M R; Kim, W K; Lee, V et al. (2009) Changes in MRS neuronal markers and T cell phenotypes observed during early HIV infection. Neurology 72:1465-72
Rosenberg, Eric S; Davidian, Marie; Banks, H Thomas (2007) Using mathematical modeling and control to develop structured treatment interruption strategies for HIV infection. Drug Alcohol Depend 88 Suppl 2:S41-51
Seth, Nilufer; Kaufmann, Daniel; Lahey, Timothy et al. (2005) Expansion and contraction of HIV-specific CD4 T cells with short bursts of viremia, but physical loss of the majority of these cells with sustained viral replication. J Immunol 175:6948-58
Altfeld, Marcus; Addo, Marylyn M; Shankarappa, Raj et al. (2003) Enhanced detection of human immunodeficiency virus type 1-specific T-cell responses to highly variable regions by using peptides based on autologous virus sequences. J Virol 77:7330-40
Thorner, Anna; Rosenberg, Eric (2003) Early versus delayed antiretroviral therapy in patients with HIV infection : a review of the current guidelines from an immunological perspective. Drugs 63:1325-37
Yu, Xu G; Shang, Hong; Addo, Marylyn M et al. (2002) Important contribution of p15 Gag-specific responses to the total Gag-specific CTL responses. AIDS 16:321-8
Yu, Xu G; Addo, Marylyn M; Rosenberg, Eric S et al. (2002) Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J Virol 76:8690-701
Altfeld, Marcus; van Lunzen, Jan; Frahm, Nicole et al. (2002) Expansion of pre-existing, lymph node-localized CD8+ T cells during supervised treatment interruptions in chronic HIV-1 infection. J Clin Invest 109:837-43

Showing the most recent 10 out of 14 publications